Medical Economist & Author
J.D. Kleinke is a medical economist, author, health care business strategist, and entrepreneur. He has been instrumental in the creation of four health care information organizations, served on the Boards of several public and privately held health care companies, and advised both sides of the political aisle on pragmatic approaches to health policy and legislation. He is currently a Wall Street Journal Expert Panelist, a mentor to several health care start-ups, and a regular contributor to The Huffington Post.
Companies like Aetna, Amgen, Cigna, Eli Lilly, Genentech, Google, Medtronic, Microsoft, Novartis, Pfizer, United Healthcare and Wellpoint have benefited from his business, product and technology strategy services, which he provides to both start-ups and established companies.
In 2012, he was a Resident Fellow of the American Enterprise Institute. Prior to joining AEI, Kleinke was Co-Founder and CEO of Mount Tabor, a health care information technology development company created in 2007 to plan, design, build, test and launch systems for the transformation and movement of electronic medical information. In 2004, he founded the Omnimedix Institute, a 501-c-3 charitable organization dedicated to the development and promotion of technologies that give patients and their families safe and secure access to, and control over, their own medical data. Prior to creating Omnimedix, Kleinke helped establish Health Grades Inc., which he served as Executive Vice Chairman of the Board until 2006.
In the 1990s, Kleinke helped grow HCIA / Solucient from a niche hospital data analysis firm into a pioneering, publicly-traded health information products and services company. Before joining HCIA, he was Director of Corporate Programs at Sheppard Pratt Health System, the largest private psychiatric hospital in the U.S. While at Sheppard Pratt, Kleinke developed and managed – at the age of 28 – the nation’s first provider-based, managed mental health care system.
Kleinke is the author of two books on the U.S. health care system – Bleeding Edge: The Business of Health Care in the New Century (1998) and Oxymorons: The Myth of a US Health Care System (2001) – and Catching Babies (2011), a novel that explores the training and culture of obstetric medicine. His work has appeared in the Wall Street Journal, New York Times, Barron’s, Health Affairs, JAMA, the British Medical Journal, Modern Healthcare, Managed Healthcare, Forbes.com, The Health Care Blog, RealClearMarkets, and The Huffington Post.
For both consulting clients and conference audiences across the health care, medical, corporate, policy and patient communities, J.D. provides a pragmatic and often humorous look at the collision of government reform, increasing patient economic empowerment, and emerging information and medical technologies – and their combined effects on the future challenges and opportunities for today’s health care organization.
eHealth 2.0: The Once & Future Healthcare Information Revolution
A new generation of health information technology is emerging – and this one may finally ready for primetime, thanks to $17.2 billion in Federal funding. Beyond the government’s sudden willingness to finance the computerization of health care, there has been explosive growth in e-prescribing and other electronic medical tools, as a new generation of providers comes online - and as patient communities have also emerged online, allowing patients to share exquisite details about their medical conditions and experiences. To attract and retain the most lucrative (i.e., well-off, well-insured and web-enabled) segments of the market, providers and payers at the vanguard are promoting the use of provider/patient e-visits and remote systems to manage disease, track changes in symptoms, and share data. New reimbursement methods and models – including insurer-paid e-visits and annual “connectivity” fees from patients – are emerging in parallel with these technologies, as the health IT community finally addresses the need for privacy, security, physician income preservation, and liability protection. The sum total of these trends is the long overdue computerization of health care, and the "liquification" of patient data from paper charts and institutional silos - with far-reaching strategic consequences for every organization in health care. This session will outline how your organization can avoid the technical pitfalls and seize the market opportunities associated with this long overdue connectivity between providers and patients.
The Patient Is In: Healthcare’s Next Economic Revolution
Over the past two decades, the locus of medical decision making – via the rise and fall of “managed care” - has shifted from physician to health plan to patient. Tiered co-payments and the introduction of high-deductible health insurance, coupled with Health Savings Accounts, are ushering in the inevitable decline of first-dollar coverage by health plans and the often irrational demand-inducement behavior of consumers. How will people behave when they are confronted daily with a financial document that looks like a 401(k) plan statement - one which shrinks with every doctor visit, lab test, new prescription and refill? Everything we think we know about how consumers will behave when purchasing routine care from these new cash accounts - and about how desperately ill patients will behave when confronted with draining those same accounts when fighting a life-threatening illness - is completely speculative. This session examines key moments in health care system history and policy for clues as to what the future will hold for all of us, not just as patients, but as real health care consumers.
Risky Hospital Business 2: Remake of the 1990s Managed Care Classic
Buried not so deep in President Obama’s health reform plan are radical changes in provider payment methodologies. Accountable Care Organizations, Medical Homes, Electronic Medical Record-related subsidies and penalties – these are only a few of the latest attempts to correct the health system’s economic, behavioral and organizational disorders a century in the making. The cost and quality problems that gave rise to the national managed care companies in the 1990s have not gone away, inspiring both the government and large health plans to simultaneously revisit many of those same managed care strategies. Will this second round - and double dose - of harsh economic medicine prove worse than the disease? Or are certain aspects of health care’s cost and quality problems simply incurable? How can provider organizations cope with a system that, as the government and payers attempt to re-engineer it around reimbursement, seems to yield only more chaos? This session will outline how your organization can navigate the latest attempt to use reimbursement and other payment reforms to re-engineer the U.S. health care system.
American Medicine 2.0: The Revolution Will Be Computerized
Many of the core provisions of the new health reform plan are already finding their way into the business strategies of the larger health plans and more aggressive provider systems. These include the bundling of provider payments – with bonuses for good outcomes and penalties for bad ones - to hospitals and physicians for both high-dollar acute cases; transfer of financial risk from insurers and the government to “accountable care organizations” for the aggregate cost of chronically ill patients, also with bonuses and penalties driven by reported outcomes; and rapid adaption of current clinical information systems and/or the re-engineering of antiquated clinical workflows. All of these new initiatives are highly dependent on major expansions in the availability of patient clinical data - including all lab and imaging data and related studies – along with the creation of new information flows within and across provider systems. The aggregate effect of these ultimately inter-related initiatives will translate into new opportunities for clinical integration. This session will outline how your organization can avoid the pitfalls and seize the opportunities associated with this long overdue computerization of American medicine.